Home > Clinical Trials
Check All Search

Saved trials

COMPLETED
NCT04132960
Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
186 Enrollment(s)
15 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Tumors
RECRUITING
NCT05845450
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
140 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Colorectal Cancer


Resectable Colorectal Carcinoma
TERMINATED
NCT03505710
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
181 Enrollment(s)
21 Study location(s)
INTERVENTIONAL (PHASE2)
Non-Small Cell Lung Cancer
RECRUITING
NCT06809764
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)
150 Enrollment(s)
23 Study location(s)
OBSERVATIONAL (None)
Non-small Cell Lung Cancer
TERMINATED
NCT05066789
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
100 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease
ACTIVE_NOT_RECRUITING
NCT03129490
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
11,000 Enrollment(s)
38 Study location(s)
INTERVENTIONAL (PHASE4)
Atrial Fibrillation


Atrial Flutter
ACTIVE_NOT_RECRUITING
NCT03129555
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
5,000 Enrollment(s)
26 Study location(s)
INTERVENTIONAL (PHASE4)
Deep Vein Thrombosis


Pulmonary Embolism
RECRUITING
NCT06957366
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
920 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (NA)
Atrial Fibrillation (AF)


VTE